We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+10%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$44.5B
AUM Growth
-$1.18B
(-2.6%)
Cap. Flow
-$4.15B
Cap. Flow
% of AUM
-9.34%
Top 10 Holdings %
Top 10 Hldgs %
9.83%
Holding
3,927
New
652
Increased
690
Reduced
847
Closed
1,056
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$309M |
| 2 |
ExxonMobil
XOM
|
+$302M |
| 3 |
Amazon
AMZN
|
+$291M |
| 4 |
Citigroup
C
|
+$253M |
| 5 |
Shopify
SHOP
|
+$238M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Humana
HUM
|
+$383M |
| 2 |
Johnson & Johnson
JNJ
|
+$312M |
| 3 |
JPMorgan Chase
JPM
|
+$285M |
| 4 |
AT&T
T
|
+$191M |
| 5 |
Dollar General
DG
|
+$187M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.63% |
| 2 | Financials | 15.61% |
| 3 | Technology | 14.28% |
| 4 | Consumer Discretionary | 13.21% |
| 5 | Industrials | 5.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
476
GXO Logistics
GXO
$6.06B
| $18.2M | 0.04% |
427,200
-314,124
| -42% | -$12.6M |
|
477
PUT
State Street SPDR S&P Biotech ETF
XBI
$10.1B
| $18.1M | 0.04% |
218,600
-355,100
| -62% | -$28.7M |
|
478
Cenovus Energy
CVE
$54.6B
| $18.1M | 0.04% |
934,436
-1,325,350
| -59% | -$25.4M |
|
479
PENN Entertainment
PENN
$2.74B
| $18.1M | 0.04% |
610,497
+41,623
| +7% | +$1.35M |
|
480
Nexstar Media Group
NXST
$5.6B
| $18M | 0.04% |
+103,001
| New | +$18.1M |
|
481
Teekay Tankers
TNK
$2.63B
| $18M | 0.04% |
583,416
+223,057
| +62% | +$7.09M |
|
482
Whirlpool
WHR
$2.42B
| $17.9M | 0.04% |
126,700
+86,320
| +214% | +$12.3M |
|
483
Crown Holdings
CCK
$12.8B
| $17.9M | 0.04% |
+217,792
| New | +$17.4M |
|
484
Deere & Co
DE
$170B
| $17.9M | 0.04% |
41,724
+41,107
| +6,662% | +$16.7M |
|
485
Viridian Therapeutics
VRDN
$2.13B
| $17.9M | 0.04% |
611,457
+2,795
| +0.5% | +$64.4K |
|
|
STOR
486
DELISTED
STORE Capital Corporation
STOR
| $17.9M | 0.04% |
557,060
+283,733
| +104% | +$9M |
|
|
487
Dollar General
DG
$25.9B
| $17.8M | 0.04% |
72,132
-757,170
| -91% | -$187M |
|
488
Array Technologies
ARRY
$818M
| $17.8M | 0.04% |
+918,630
| New | +$17.4M |
|
489
PUT
iShares US Real Estate ETF
IYR
$4.59B
| $17.8M | 0.04% |
210,900
+99,700
| +90% | +$8.37M |
|
490
FerroAtlántica
GSM
$628M
| $17.7M | 0.04% |
4,610,322
+150,728
| +3% | +$750K |
|
491
Nutanix
NTNX
$14.9B
| $17.7M | 0.04% |
680,357
-1,047,343
| -61% | -$28.6M |
|
492
Mondelez International
MDLZ
$77.7B
| $17.7M | 0.04% |
265,755
-219,117
| -45% | -$13.9M |
|
493
CALL
iShares MSCI Brazil ETF
EWZ
$9.05B
| $17.6M | 0.04% |
628,100
+434,200
| +224% | +$13.3M |
|
|
WPCB
494
DELISTED
Warburg Pincus Capital Corporation I-B
WPCB
| $17.5M | 0.04% |
1,732,872
| – | – |
|
|
PR
495
Permian Resources
PR
$17.9B
| $17.4M | 0.04% |
1,854,436
-3,457,946
| -65% | -$33.1M |
|
496
W.W. Grainger
GWW
$65.3B
| $17.4M | 0.04% |
+31,337
| New | +$17.7M |
|
497
Motorola Solutions
MSI
$69.4B
| $17.4M | 0.04% |
+67,616
| New | +$16.9M |
|
498
Monster Beverage
MNST
$91.4B
| $17.4M | 0.04% |
343,096
-522,742
| -60% | -$25.3M |
|
499
Blackstone Secured Lending
BXSL
$5.41B
| $17.4M | 0.04% |
+779,170
| New | +$18.3M |
|
500
Intuit
INTU
$81.1B
| $17.4M | 0.04% |
44,659
+5,284
| +13% | +$2.1M |
|
Similar funds
Marshall Wace's Q4 2022 Portfolio in Review
As of Q4 2022, Marshall Wace held 3,927 positions worth $44.5B, down 2.6% from $45.6B the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.
Marshall Wace withdrew a net $4.15B in Q4 2022, closing 1,056 positions and reducing 847 holdings. Its most notable exit was Humana, an estimated $383M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Financials and Technology.
Against the trend, Marshall Wace opened a new position in Elevance Health worth $188M.
- Marshall Wace's largest Q4 2022 buy was Elevance Health: 366,649 shares worth $188M.
- Marshall Wace added most to Biogen in Q4 2022, an estimated $309M increase.
- Marshall Wace's biggest Q4 2022 reduction was Johnson & Johnson, cutting an estimated $312M.
- Marshall Wace fully exited Humana in Q4 2022, selling an estimated $383M.
- Marshall Wace's ten largest holdings make up 9.8% of its $44.5B portfolio in Q4 2022.
- Marshall Wace opened 652 new positions and closed 1,056 in Q4 2022.
- Marshall Wace's portfolio value fell 2.6% quarter-over-quarter to $44.5B.
Based on Marshall Wace's 13F filing for Q4 2022, filed 14 Feb 2023.